Methods and compositions for determining blood levels of pod protein

A pod protein and level technology, which is applied in measuring devices, biological testing, biomaterial analysis, etc., can solve the problems of lack of clinical diagnostic methods for measuring pod protein

Active Publication Date: 2021-05-07
NINGBO ZIYUAN MEDICAL DEVICES INC
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although pod protein as a target is attractive for the advancement of anticancer drug design and drug research on this target, there is a lack of an automated way to measure the blood level of pod protein by clinical chemistry analyzer or automated immunoassay analyzer clinical diagnostic methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for determining blood levels of pod protein
  • Methods and compositions for determining blood levels of pod protein
  • Methods and compositions for determining blood levels of pod protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach 1

[0070]Embodiment 1: A method for determining blood levels of pod protein molecules, said method comprising:

[0071] 1) combining a serum sample or plasma sample containing or suspected to contain a podin molecule with one or more antibodies of a specific size coated with one or more antibodies directed against the human podin molecule or one or more degraded fragments thereof particle mixing;

[0072] 2) measuring the optical change or signal change of the reaction mixture and using the optical change or signal change to calculate the sample by comparing the optical change or signal change with a calibrator of known concentration of pod protein concentration of pod protein molecules in

[0073] 3) The concentration of pod protein in the sample is compared to a normal reference range or a cut-off value above which a higher risk of cancer is indicated.

Embodiment approach 2

[0074] Embodiment 2: The method according to embodiment 1 , wherein said pod protein molecule is of mammalian, preferably human, origin and is an asparaginyl endopeptidase [EC 3.4.22.34].

Embodiment approach 3

[0075] Embodiment 3: The method according to embodiment 1, wherein said antibody is a monoclonal antibody having specific affinity for a mammalian pod protein molecule, preferably a human pod protein molecule or one or more proteolytically degraded fragments thereof or polyclonal antibodies.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

In one aspect, disclosed herein is a homogeneous assay method for determining blood levels of a pod protein molecule (asparaginyl endopeptidase). In one aspect, the assay utilizes nanoparticles of a specific size coated with one or more antibodies specific for the podin molecule or one or more fragments thereof. In one aspect, the assay is designed in a homogeneous manner to have a dynamic range of 0.2 ng / mL to 160 ng / mL. In another aspect, disclosed herein is a kit for determining blood levels of podin, said kit comprising two parts of reagents (R1 and R2), said kit being suitable for use on a clinical chemistry analyzer use. In one aspect, the cutoff value for distinguishing normal risk from high risk for cancers such as breast cancer, colorectal cancer, and gastric cancer is 18 ng / mL ± 3 ng / mL.

Description

technical field [0001] In certain aspects, the present disclosure relates to methods, kits, and devices for analyzing biomolecules. In particular aspects, the present disclosure relates to methods, kits, and devices for determining the concentration of legumain in a sample. In some embodiments, the concentration of legume protein in a blood sample is determined by a microparticle-enhanced immunoassay, such as a latex agglutination immunoassay. Background technique [0002] Pod protein is a protein encoded by the LGMN gene in humans (Chen J.M. et al., J. Biol. Chem. 1997; Tanaka T. et al., Cytogenet. Cell Genet. 1966; Halfon S. et al., FEBS Lett. 1998). This gene encodes a cysteine ​​protease with strict specificity for the hydrolysis of asparaginyl bonds, cleaving peptide bonds with Asn or Asp at the P1 position (Schwarz G. et al., J. Biol. Chem. 2002) . Several alternatively spliced ​​transcript variants have been described, but the biological availability of only two ha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/574G01N33/68
CPCG01N33/57484G01N33/68G01N33/54333G01N2333/95G01N33/57496G01N2333/96466
Inventor 余笑虹郭芳
Owner NINGBO ZIYUAN MEDICAL DEVICES INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products